SCHEMBL16628717

SCHEMBL16628717

CN(Cc1cccnc1)C(=O)c1nc(N)nc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
HTR2C P28335 1/20 0.49
GBA1 P04062 1/20 0.49
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
RIPK1 Q13546 1/20 0.46
RAB9A P51151 1/20 0.45
CLK1 P49759 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081057 0.89 CYP3A4 (0.53) CYP3A4CYP2D6MEN1KMT2A
SCHEMBL13144371 0.84 ADORA2A (0.49) GBA1CYP3A4CYP2D6MEN1CYP1A2
SCHEMBL16628712 0.82 ADORA3 (0.56)
SCHEMBL16628732 0.82 APP (0.52) LMNACYP3A4CYP2D6MEN1CYP1A2
SCHEMBL3087952 0.81 APP (0.48) KMT2ATDP1
SCHEMBL13144374 0.81 AOC3 (0.46) CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3090418 0.81 SCD5 (0.52) CYP3A4CYP2D6MEN1HPGDKMT2A
SCHEMBL16628815 0.80 ADORA3 (0.58) MEN1KMT2ATDP1CLK1
SCHEMBL13180096 0.80 CYP3A4 (0.47) CYP3A4CYP2D6
SCHEMBL16628770 0.79 HPGD (0.55) LMNAGBA1CYP3A4CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed